Filing Details
- Accession Number:
- 0001209191-19-049203
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-11 17:12:53
- Reporting Period:
- 2019-09-09
- Accepted Time:
- 2019-09-11 17:12:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1606645 | Foamix Pharmaceuticals Ltd. | FOMX | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727727 | Ilan Hadar | C/O Foamix Pharmaceuticals Ltd. 2 Holzman Street Rehovot L3 7670402 | Cfo & Country Manager | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-09-09 | 9,420 | $3.50 | 123,671 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-09-10 | 34,392 | $3.50 | 89,279 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2019.
Billionaire Hedge Funds
